Belgian stocks finished the trading session on Friday under pressure, with the BEL 20 index ending the day down 0.91% at the Brussels close. Sector weakness in Healthcare, Utilities and Financials contributed to the overall decline.
Among individual movers on the BEL 20, Azelis Corporate Services NV (EBR:AZE) was the session's top performer, rising 6.67% - a gain of 0.69 points - to close at 11.04. Melexis NV (EBR:MLXS) followed, adding 2.26% or 1.55 points to finish at 70.20. Anheuser Busch Inbev SA NV (EBR:ABI) also posted a modest increase, up 0.39% or 0.24 points to 62.16 late in the session.
On the downside, UCB SA (EBR:UCB) was the weakest stock, falling 2.96% - a decline of 7.30 points - to end at 239.00. Argen-X (EBR:ARGX) dropped 2.80% or 19.20 points to finish at 666.20, while KBC Groep NV (EBR:KBC) declined 1.62% or 1.85 points to close at 112.70.
Market breadth favored decliners on the Brussels Stock Exchange, where falling stocks outnumbered advancing ones by 51 to 35, and 19 issues finished unchanged.
Commodity markets showed mixed activity. Gold futures for June delivery rose 0.40% - an increase of 18.74 - to $4,742.74 a troy ounce. Crude oil for June delivery moved lower, falling 2.36% or 2.26 to $93.59 a barrel, while the June Brent contract eased 0.50% or 0.53 to trade at $104.54 a barrel.
In currency markets, EUR/USD was unchanged 0.30% to 1.17, while EUR/GBP unchanged 0.02% to 0.87. The US Dollar Index Futures was down 0.24% at 98.37.
These price moves left the BEL 20 with a clear single-session retreat, driven by sector-level weakness and a greater number of declining issues than advancing ones. The session's top and bottom performers spanned chemicals and healthcare to banking and consumer staples, reflecting a mixed intra-index dynamic.
Investors monitoring the Belgian market will note the divergence between select stock gains and broader sector headwinds as the market closed for the week.